Skip to main content
padlock icon - secure page this page is secure

Prevention of cardiac disease: lifestyle modification or pharmacotherapy?

Buy Article:

$47.00 + tax (Refund Policy)


Cardiovascular disease is still the leading cause of death in Australia. There have recently been significant advances in the management of acute coronary syndromes, as well as secondary prevention strategies; however, much of our resources are still directed towards treatment rather than prevention. Prevention of cardiovascular disease involves first, identifying patients at greatest risk of cardiovascular events and second, managing modifiable risk factors. Both pharmacotherapy and lifestyle modification are useful in modifying risk factors; however, the relative importance of each is often dictated by the risk factor profile of the individual. Although there is growing evidence that those at all levels of risk may benefit from lifestyle modification, pharmacotherapy is likely to be most useful in those at higher risk.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: atherosclerosis; hypercholesterolaemia

Document Type: Research Article

Affiliations: Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Publication date: 01 March 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more